This report provides exclusive insights into the COVID-19 impact on the Bioactive Wound Care Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Bioactive Wound Care Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Bioactive Wound Care Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by
Infinium Global Research on bioactive wound care market provides in-depth
analysis of segments and sub-segments in the global as well as regional
bioactive wound care market. The study also highlights the impact of drivers,
restraints, and macro indicators on the global and regional bioactive wound
care market over the short term as well as long term. The report is a comprehensive
presentation of trends, forecast and dollar values of global bioactive wound
care market. According to the report, the global bioactive wound care market is
projected to grow at a CAGR of 6.4% over the forecast period of 2019-2025.

Market Insight
Bioactive wound care dressing is a sterile pad comprises of bioactive substances which control and cure acute and
chronic wounds. Bioactive wound care products are derived from artificial and
natural sources play an important role in the wound healing process.
Bioactive wound care dressings involve different materials such as alginates,
chitosan, keratin, collagen, elastin, and hydrocolloids, which actively
participate in healing wounds and fighting infections. Bioactive wound
dressings reduce leakage, pain, and odor resulting from wounds, apart from this
it is a cost-effective method of wound care. Bioactive dressing surpasses
conventional dressing procedure owing to advantages such as fast healing time,
control over the infection alleviate pain and discomfort.
Growing prevalence of chronic
diseases such as diabetics and cancer drives the growth of bioactive wound care
market. Furthermore, rising diabetic population with associated risks of
diabetic foot ulcers, pressure sores are increasing the demand of bioactive
wound care products. According to the world health organization, 1.6 million
deaths are directly attributed to diabetes each year. Furthermore, according to the world health
organization the global cancer burden is estimated to have risen to 18.1
million new cases and 9.6 million deaths in 2018. In addition, a rise in the
incidence of chronic injuries and an increased number of surgical procedures
are contributing to the growth of the market. Moreover, increasing awareness
towards efficient and less time-consuming healthcare treatments among the
population, as well as augmented demand for the bioactive material provides
beneficial opportunities for the bioactive wound care market. However high cost
associated with treatment, less expenditure on research and development for the
synthesis of advanced bioactive wound care product can hinder the growth of the
bioactive wound care market.
Among the regions, North America
dominated the bioactive wound care market with the market share of more than
40% followed by Europe. Rising awareness among the population, favorable
reimbursement system and sophisticated healthcare system, rapidly aging
population and presence of various leading market players are some factors
contribute to the growth of bioactive wound care market in the region. Asia
Pacific region is fastest growing region owing to the highest number of a
diabetic patient with diabetic foot ulcers, pressure sores infections, and other
chronic diseases, as well as rising demand for bioactive wound care products in
the region, provides beneficial opportunities for the bioactive wound care
market. According to NCBI, two-thirds of the world's population lives in the
Asia Pacific region where the prevalence of diabetes has reached epidemic
proportion. With China and India being the most populous nations on the globe,
it is believed that over 150 million diabetes resides in the region with more
than 95% being of type 2 diabetes mellitus.
Segment Covered
The report on global bioactive
wound care market covers segments such as product type, and end users. On the
basis of product type, the sub-markets include moist wound care, antimicrobial
wound care, and active wound care. On the basis of end users, the sub-markets
include ambulatory surgical centers, hospitals & clinics, and other end
users.
Companies Profiled:
The report provides profiles of
the companies in the market such as BSN Medical, Systagenix Wound Management
Ltd., Mölnlycke Health Care, ConvaTec Inc., Paul Hartmann AG, Smith &
Nephew, Covalon Technologies Inc, Organogenesis Inc, 3M Health Care, Medtronic plc,
and Other companies.
Report Highlights:
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of bioactive wound care market. Moreover, the study highlights current
market trends and provides forecast from 2019-2025. We also have highlighted
future trends in the market that will affect the demand during the forecast
period. Moreover, the competitive analysis given in each regional market brings
an insight into the market share of the leading players.